SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-22-000236
Filing Date
2022-01-04
Accepted
2022-01-04 09:09:40
Documents
15
Period of Report
2022-01-03
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 49944
2 ex10-1.htm EX-10.1 96899
3 ex10-2.htm EX-10.2 33560
4 ex99-1.htm EX-99.1 14037
  Complete submission text file 0001493152-22-000236.txt   403485

Data Files

Seq Description Document Type Size
5 INLINE XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT cytr-20220103.xsd EX-101.SCH 2740
6 INLINE XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT cytr-20220103_lab.xml EX-101.LAB 34476
7 INLINE XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT cytr-20220103_pre.xml EX-101.PRE 22589
9 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3571
Mailing Address 11726 SAN VICENTE BOULEVARD SUITE 650 LOS ANGELES CA 90049
Business Address 11726 SAN VICENTE BOULEVARD SUITE 650 LOS ANGELES CA 90049 310-826-5648
CYTRX CORP (Filer) CIK: 0000799698 (see all company filings)

IRS No.: 581642750 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-15327 | Film No.: 22504235
SIC: 2836 Biological Products, (No Diagnostic Substances)